Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Korea SE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Shin Poong Pharmaceutical Co Ltd

+ Add to Watchlist

019175:KS

3,640 KRW 135 3.58%

As of 02:06:52 ET on 05/06/2015.

Snapshot for Shin Poong Pharmaceutical Co Ltd (019175)

Open: 3,775 Day's Range: 3,610 - 3,780 Volume: 13,984
Previous Close: 3,775 52wk Range: 2,630 - 4,050 1-Yr Rtn: +25.92%

Stock Chart for 019175

No chart data available.
  • 019175:KS 3,640
  • 1D
  • 1M
  • 1Y
3,775
Interactive 019175 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 019175

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. KOSPI -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M KRW) 8,008.00
Shares Outstanding (M) 2.20
30 Day Average Volume 37,666
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.72%
Cash Dividend (KRW) 62.4995
Dividend Ex-Date 12/29/2014
5 Year Dividend Growth -2.82%
Next Earnings Announcement 05/15/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 019175

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 019175

Shin Poong Pharmaceutical Co., Ltd. manufactures pharmaceutical raw materials and prescription drugs, such as cephalosporin antibiotics, hemostatics, sedative agents, and anti-diabetics.

Ryu Jei-ManRep DirectorKim Byeong-YongExecutive Director
More Company Profile & Key Executives for 019175

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil